Papillary Thyroid Cancer Latest Advances
Find the Latest Research About Papillary Thyroid Cancer
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13902 publications
Association of Interleukin 17 Polymorphisms and IL17A Levels with Papillary Thyroid Carcinoma: A Hospital-Based Study in the Chinese Population.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: June 24, 2026
Targeted therapy of highly aggressive thyroid papillary carcinoma by AS1411-guided nanomaterials.
Journal: Nanomedicine (London, England)
Published: June 23, 2026
Methyltransferase-like protein 7B promotes glycolysis and malignant progression in papillary thyroid carcinoma via the USP28/HIF-1α axis
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: June 22, 2026
Management of Differentiated Thyroid Cancer.
Journal: The New England journal of medicine
Published: June 17, 2026
Correction to: FOXK2/SH2D3A axis recruits EGFR to drive papillary thyroid cancer progression and confers sensitivity to EGFR inhibition.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 16, 2026
Corrigendum to: A Novel Cuproptosis-Related Gene Signature Predicts Prognosis in Papillary Thyroid Carcinoma Patients.
Journal: Combinatorial chemistry & high throughput screening
Published: June 15, 2026
MicroRNA expression signatures associated with metastatic progression in papillary thyroid carcinoma.
Journal: Archives of endocrinology and metabolism
Published: June 11, 2026
Postoperative stimulated thyroglobulin and the ps-tg/TSH ratio enhance the 2025 ATA risk stratification for predicting radioiodine response in papillary thyroid carcinoma.
Journal: Annals of medicine
Published: June 08, 2026
Association between mixed exposure to 11 urinary metal elements and the risk of thyroid cancer: a case-control study
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: June 08, 2026
RET Fusion-Positive Solid Tumor
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: June 04, 2026
Retraction notice to "Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved" [Arch. Biochem. Biophys. 689 (2020) 108461].
Journal: Archives of biochemistry and biophysics
Published: June 04, 2026
Last Updated: 06/30/2026